日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.

Linavonkibart 和 pembrolizumab 治疗免疫检查点阻断耐药的晚期实体瘤:一项 1 期试验。

Yap Timothy A, Sweis Randy F, Vaishampayan Ulka, Kilari Deepak, Gainor Justin F, McKean Meredith, Barve Minal, Tarhini Ahmad A, Bockorny Bruno, Sonpavde Guru, Park David, Babu Sunil, Ju Yawen, Liu Lan, Henry Susan, Tirucherai Giridhar S, DeWall Stephen, Qatanani Mohammed, Marantz Jing L, Gan Lu

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

普拉替尼治疗晚期RET融合阳性非小细胞肺癌患者的I/II期ARROW研究的最终疗效和安全性数据

Besse, Benjamin; Subbiah, Vivek; Curigliano, Giuseppe; Bowles, Daniel W; Doebele, Robert C; Mansfield, Aaron S; Baik, Christina S; de Lima Lopes, Gilberto; Paz-Ares, Luis; Taylor, Matthew H; Tan, Daniel S W; Alonso, Guzman; Gadgeel, Shirish M; Kalemkerian, Gregory P; Ou, Sai-Hong Ignatius; van der Wekken, Anthonie J; Becerra, Carlos R; Evangelist, Makenzi; Griesinger, Frank; Liu, Stephen V; Lou, Yanyan; Mazières, Julien; Melear, Jason M; Narang, Mohit; Saxena, Ashish; Thomas, Michael; Wang, Sophia; Thomassen, Amber; Lee, Dae Ho; Kim, Dong-Wan; Gainor, Justin F

Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody Tarlatamab.

循环肿瘤细胞可预测对靶向 DLL3 的双特异性抗体 Tarlatamab 的反应。

Mishra Avanish, Meador Catherine B, Kikkeri Kruthika, Cunneely Quinn, Lin Maoxuan, Carmona-LaSalle Thomas J, Huang Shih-Bo, Bell Remy, Putaturo Victor, Xia Weikun, Liang Joyce H, Fang Jacy, San Vicente Sarah, Zielinski Caroline E, Digumarthy Subba R, Hung Yin P, Yeap Beow Y, Edd Jon F, Lawrence Michael S, Sade-Feldman Moshe, Sen Debattama R, Toner Mehmet, Maheswaran Shyamala, Gainor Justin F, Haber Daniel A

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

RET 改变实体瘤中选择性 RET 抑制剂耐药的基因组机制图谱:RETregistry 全球联盟分析

Waliany, Sarah; Cooper, Alissa J; Liu, Stephen V; Gautschi, Oliver; Rotow, Julia K; Smith, Katherine Emilie Rhoades; Weber, Urs M; Lee, Dae Ho; Loong, Herbert H F; Patel, Jyoti D; Pennell, Nathan A; Nagasaka, Misako; Patel, Shetal A; Tan, Daniel S W; Solomon, Benjamin J; Kim, Tae Min; Pall, Georg; Riess, Jonathan W; Sun, Lova; Früh, Martin; Uy, Natalie F; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B; Baik, Christina S; Lai, Gillianne G Y; Ou, S Ignatius; Cheung, Kingsley S Y; Patil, Tejas; Mansfield, Aaron S; Weiler, Daniela; Yeap, Beow Y; Wirth, Lori J; Gainor, Justin F; Drilon, Alexander; Lin, Jessica J

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study

在II期至III期非小细胞肺癌患者计划接受新辅助化疗免疫治疗后,进行根治性放疗(联合或不联合化疗):一项国际多中心回顾性研究

Adib, Elio; Nassar, Amin H; Lee, Katie N; Fusco, Francesca; Crowley, Fionnuala; Baena, Javier; Worth, John Emmett; Abi Jaoude, Joseph; Addeo, Alfredo; Bou Farhat, Elias; Rakaee, Mehrdad; Amini, Arya; Lambden, Jason; Rost, Maximilian; Bolnykh, Iakov; Aboubakar Nana, Frank; Aujayeb, Avinash; Cortellini, Alessio; Newsom-Davis, Thomas; Camidge, D Ross; Vitzthum, Lucas K; Cappuzzo, Federico; Marron, Thomas U; Lanuti, Michael; Gainor, Justin F; Kwiatkowski, David J; Park, Henry S; Owen, Dawn; Keane, Florence K

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

作者更正:CTLA4阻断可消除KEAP1/STK11相关的PD-(L)1抑制剂耐药性

Skoulidis, Ferdinandos; Araujo, Haniel A; Do, Minh Truong; Qian, Yu; Sun, Xin; Cobo, Ana Galan; Le, John T; Montesion, Meagan; Palmer, Rachael; Jahchan, Nadine; Juan, Joseph M; Min, Chengyin; Yu, Yi; Pan, Xuewen; Arbour, Kathryn C; Vokes, Natalie; Schmidt, Stephanie T; Molkentine, David; Owen, Dwight H; Memmott, Regan; Patil, Pradnya D; Marmarelis, Melina E; Awad, Mark M; Murray, Joseph C; Hellyer, Jessica A; Gainor, Justin F; Dimou, Anastasios; Bestvina, Christine M; Shu, Catherine A; Riess, Jonathan W; Blakely, Collin M; Pecot, Chad V; Mezquita, Laura; Tabbó, Fabrizio; Scheffler, Matthias; Digumarthy, Subba; Mooradian, Meghan J; Sacher, Adrian G; Lau, Sally C M; Saltos, Andreas N; Rotow, Julia; Johnson, Rocio Perez; Liu, Corinne; Stewart, Tyler; Goldberg, Sarah B; Killam, Jonathan; Walther, Zenta; Schalper, Kurt; Davies, Kurtis D; Woodcock, Mark G; Anagnostou, Valsamo; Marrone, Kristen A; Forde, Patrick M; Ricciuti, Biagio; Venkatraman, Deepti; Van Allen, Eliezer M; Cummings, Amy L; Goldman, Jonathan W; Shaish, Hiram; Kier, Melanie; Katz, Sharyn; Aggarwal, Charu; Ni, Ying; Azok, Joseph T; Segal, Jeremy; Ritterhouse, Lauren; Neal, Joel W; Lacroix, Ludovic; Elamin, Yasir Y; Negrao, Marcelo V; Le, Xiuning; Lam, Vincent K; Lewis, Whitney E; Kemp, Haley N; Carter, Brett; Roth, Jack A; Swisher, Stephen; Lee, Richard; Zhou, Teng; Poteete, Alissa; Kong, Yifan; Takehara, Tomohiro; Paula, Alvaro Guimaraes; Parra Cuentas, Edwin R; Behrens, Carmen; Wistuba, Ignacio I; Zhang, Jianjun; Blumenschein, George R; Gay, Carl; Byers, Lauren A; Gibbons, Don L; Tsao, Anne; Lee, J Jack; Bivona, Trever G; Camidge, D Ross; Gray, Jhannelle E; Leighl, Natasha B; Levy, Benjamin; Brahmer, Julie R; Garassino, Marina C; Gandara, David R; Garon, Edward B; Rizvi, Naiyer A; Scagliotti, Giorgio Vittorio; Wolf, Jürgen; Planchard, David; Besse, Benjamin; Herbst, Roy S; Wakelee, Heather A; Pennell, Nathan A; Shaw, Alice T; Jänne, Pasi A; Carbone, David P; Hellmann, Matthew D; Rudin, Charles M; Albacker, Lee; Mann, Helen; Zhu, Zhou; Lai, Zhongwu; Stewart, Ross; Peters, Solange; Johnson, Melissa L; Wong, Kwok K; Huang, Alan; Winslow, Monte M; Rosen, Michael J; Winters, Ian P; Papadimitrakopoulou, Vassiliki A; Cascone, Tina; Jewsbury, Philip; Heymach, John V

Oxidation of retromer complex controls mitochondrial translation

逆转录酶复合物的氧化控制线粒体翻译

Zhang, Junbing; Ali, Md Yousuf; Chong, Harrison Byron; Tien, Pei-Chieh; Woods, James; Noble, Carolina; Vornbäumen, Tristan; Ordulu, Zehra; Possemato, Anthony P; Harry, Stefan; Fonticella, Jay Miguel; Fellah, Lina; Harrison, Drew; Ge, Maolin; Khandelwal, Neha; Huang, Yingfei; Chauvin, Maëva; Bischof, Anica Tamara; Hambelton, Grace Marie; Gohar, Magdy Farag; Zhang, Siwen; Choi, MinGyu; Bouberhan, Sara; Oliva, Esther; Mino-Kenudson, Mari; Pavlova, Natalya N; Lawrence, Michael; Gainor, Justin F; Beausoleil, Sean A; Bardeesy, Nabeel; Mostoslavsky, Raul; Pépin, David; Ott, Christopher J; Liau, Brian; Bar-Peled, Liron

Spatial biology captures the effects of neoadjuvant chemo-immunotherapy in lung cancer

空间生物学捕捉了新辅助化疗免疫疗法对肺癌的影响

Chen, Jonathan H; Gainor, Justin F

Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

机器学习驱动的转移性非小细胞肺癌免疫疗法调整策略

Saad, Maliazurina B; Al-Tashi, Qasem; Hong, Lingzhi; Verma, Vivek; Li, Wentao; Boiarsky, Daniel; Li, Shenduo; Petranovic, Milena; Wu, Carol C; Carter, Brett W; Shroff, Girish S; Cascone, Tina; Le, Xiuning; Elamin, Yasir Y; Altan, Mehmet; Heeke, Simon; Sheshadri, Ajay; Chang, Joe Y; Lee, Percy P; Liao, Zhongxing; Gibbons, Don L; Vaporciyan, Ara A; Lee, J Jack; Wistuba, Ignacio I; Haymaker, Cara; Mirjalili, Seyedali; Jaffray, David; Gainor, Justin F; Lou, Yanyan; Di Federico, Alessandro; Pecci, Federica; Awad, Mark; Ricciuti, Biagio; Heymach, John V; Vokes, Natalie I; Zhang, Jianjun; Wu, Jia

Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study

Evorpacept联合利妥昔单抗治疗复发或难治性非霍奇金淋巴瘤:I期ASPEN-01研究结果

Kim, Tae Min; Lakhani, Nehal J; Soumerai, Jacob; Kamdar, Manali; Gainor, Justin F; Messersmith, Wells; Fanning, Philip; Guan, Shanhong; Jin, Feng; Forgie, Alison; Wan, Hong I; Pons, Jaume; Randolph, Sophia S; Kim, Won Seog